HIV

Researchers target new opportunities for preventive interventions.

Over the past 2 decades, advances in HIV therapy have allowed patients to manage their infection through the use of long-term medication therapy.

Pharmacist management of human immunodeficiency virus (HIV) produces earlier viral suppression in treatment-naïve patients than primary care alone.

Cell-to-cell transmission of HIV causes greater CD4 T cell death.

Experimental combination shows similar rates of HIV virologic suppression to Truvada.

Experimental drug may allow patients to take one dose per month.

HIV viral suppression at the time of birth much worse than expected.

In an effort to demonstrate the power of shared wisdom, provide a place for the HIV community to access and share information and support national HIV advocacy efforts, Janssen has announced the launch of Your Story, Your HIV Wisdom.

Tumors linked to high blood sugar can be successfully treated without affecting blood vessel growth.

Study finds substantial minority living with undiagnosed HIV infection.

Advocates seek to eradicate the disease by 2030.

Study suggests testing sites in high schools may increase the likelihood of getting an HIV test.

Pharmacists vital in helping HIV-infected women stay adherent to their treatment regimen.

Pregnancy is an important time for women with human immunodeficiency virus (HIV) to receive adequate prenatal care, antiretroviral therapy (ART), and postpartum HIV care to improve clinical outcomes for themselves and their babies.

Device may eventually detect cancer and diabetes.

Researchers target the spread of diseases such as HIV, SARS, and Ebola.

Proper nutrition leads to improved outcomes and increased CD4 T-cell counts.

Top infectious diseases articles for pharmacotherapy from last year.

Each year, the American Society of Health-System Pharmacists provides a tremendous service to pharmacists by publishing a list of significant articles on infectious diseases pharmacotherapy from the previous year.

Children vaccinated before starting HIV therapy found to be at risk.

Research may lead to a gel that instantly destroys viral particles.

Program addresses the needs of minority and minority-serving clinicians and their communities.

For more than 25 years, the Midwest AIDS Training + Education Center has educated clinicians who provide care to patients infected with human immunodeficiency virus (HIV) and those at risk for HIV.

Compound targets latent HIV proteins without harming other parts of the body.